FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

McKesson Packaging Services buPROPion Hydrochloride Extended-Release Recall

buPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, UD 100 Tablets (10 x 10)…

McKesson Packaging Services · Concord, NC

Risk level
Class III
Reported by FDA
Oct 10, 2012
Recall ID
D-002-2013
Check your lot numberHow we source this data

Summary

McKesson Packaging Services recalled buPROPion Hydrochloride Extended-Release starting Mar 29, 2012. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-002-2013 on Oct 10, 2012. Reason: Failed USP Dissolution Test Requirements: Possible out-of-specification dissolution results at the 8 hour stability testing point. Status: Terminated.

Why it was recalled

Failed USP Dissolution Test Requirements: Possible out-of-specification dissolution results at the 8 hour stability testing point.

Product description

buPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, UD 100 Tablets (10 x 10) per carton, Rx only, Mfg By: CMIC-VPS Corporation, Cranbury, New Jersey 08512; blister barcode N (01)003 63739 450 10 3, Dist By: McKesson Packaging, Concord, NC 28027; NDC 63739-450-10, carton barcode 6373945010.

Lot numbers, UPCs & expiration codes

Lot #: 0075375, 0074584, Exp 08/12

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-002-2013
Classification
Class III
Status
Terminated
Recall initiated
Mar 29, 2012
FDA report date
Oct 10, 2012
Quantity
674 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
McKesson Packaging Services

Original FDA data

Every field from FDA enforcement report D-002-2013, exactly as published.

Show all FDA fields
City
Concord
State
NC
Status
Terminated
Country
United States
Event ID
63127
Address
7101 Weddington Rd NW
Code information
Lot #: 0075375, 0074584, Exp 08/12
Postal code
28027-3412
Report date
Oct 10, 2012
Product type
Drugs
Recall number
D-002-2013
Classification
Class III
Recalling firm
McKesson Packaging Services
Product quantity
674 cartons
Termination date
Apr 11, 2013
Reason for recall
Failed USP Dissolution Test Requirements: Possible out-of-specification dissolution results at the 8 hour stability testing point.
Voluntary / mandated
Voluntary: Firm initiated
Product description
buPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, UD 100 Tablets (10 x 10) per carton, Rx only, Mfg By: CMIC-VPS Corporation, Cranbury, New Jersey 08512; blister barcode N (01)003 63739 450 10 3, Dist By: McKesson Packaging, Concord, NC 28027; NDC 63739-450-10, carton barcode 6373945010.
Distribution pattern
Nationwide
Recall initiation date
Mar 29, 2012
Initial firm notification
Letter
Center classification date
Oct 1, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-002-2013, published Oct 10, 2012. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls